Telo Genomics Corp, a biotech company developing the industry's leading telomere technology platform with diagnostic and prognostic applications measuring genomic instability in oncology, is pleased to announce that the Accreditation Committee of the College of American Pathologists (CAP) has awarded accreditation to TELO's laboratory at the MaRS Center in Toronto, Canada.
For the full article click here: Telo Genomics Receives Accreditation from College of American Pathologists